DocuSign (NASDAQ:DOCU - Get Free Report) released its earnings results on Thursday. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.02, Briefing.com reports. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The firm had revenue of $776.25 million during the quarter, compared to analyst estimates of $760.94 million. During the same quarter in the previous year, the firm earned $0.76 earnings per share. The firm's revenue for the quarter was up 9.0% compared to the same quarter last year. DocuSign updated its FY 2026 guidance to EPS and its Q1 2026 guidance to EPS.
DocuSign Trading Up 14.8 %
DOCU stock traded up $11.06 during trading on Friday, hitting $85.76. The company had a trading volume of 11,927,431 shares, compared to its average volume of 2,402,407. The firm has a market capitalization of $17.33 billion, a price-to-earnings ratio of 17.68, a P/E/G ratio of 6.94 and a beta of 1.02. The business has a 50 day moving average of $87.97 and a 200 day moving average of $79.37. DocuSign has a fifty-two week low of $48.70 and a fifty-two week high of $107.86.
Analyst Ratings Changes
Several analysts have weighed in on the stock. UBS Group lowered their target price on shares of DocuSign from $100.00 to $90.00 and set a "neutral" rating for the company in a research note on Friday. Robert W. Baird boosted their target price on shares of DocuSign from $59.00 to $100.00 and gave the company a "neutral" rating in a research note on Friday, December 6th. Hsbc Global Res upgraded shares of DocuSign to a "moderate sell" rating in a research note on Friday, December 6th. HSBC reiterated a "reduce" rating on shares of DocuSign in a research note on Friday, December 6th. Finally, Jefferies Financial Group upped their price target on shares of DocuSign from $80.00 to $95.00 and gave the stock a "buy" rating in a research report on Tuesday, December 3rd. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $95.58.
View Our Latest Stock Report on DocuSign
Insider Buying and Selling
In other DocuSign news, CFO Blake Jeffrey Grayson sold 8,000 shares of the company's stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $94.77, for a total value of $758,160.00. Following the completion of the sale, the chief financial officer now directly owns 101,439 shares of the company's stock, valued at approximately $9,613,374.03. This represents a 7.31 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Allan C. Thygesen sold 40,000 shares of the company's stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $90.04, for a total transaction of $3,601,600.00. Following the completion of the sale, the chief executive officer now directly owns 156,050 shares of the company's stock, valued at $14,050,742. The trade was a 20.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 104,422 shares of company stock valued at $9,665,394 over the last 90 days. 1.66% of the stock is currently owned by company insiders.
DocuSign Company Profile
(
Get Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More

Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.